← Leaderboards
Charles T Esmon
Oklahoma Medical Research Foundation
$7,886,182
Attributed
$21,921,359
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2005–17$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$25,923,021 · 7
By mechanism
UM1$20,052,765 · 1
P20$4,369,458 · 3
RC1$1,000,000 · 1
P50$500,798 · 2
Top collaborators
- Stephen R Wisniewski5 shared
- Kenneth G Mann3 shared
- Gary Kinasewitz2 shared
- Florea Lupu2 shared
- James H. Morrissey2 shared
Most similar at Oklahoma Medical Research Foundation
Same institution · by research overlap
- Florea Lupu$19,062,937
- Shinichiro Kurosawa$10,924,747
- Fletcher B Taylor$1,141,454
- Gary Kinasewitz$333,333
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineInflammatoryInflammatory ResponseIn VivoBloodVascular EndotheliumMediatingBlood VesselsPlasmaMediator Of Activation ProteinProteinsTissuesTranslatingTraumaHemorrhageClinically RelevantLeadClinical ResearchInjuryInflammationImmune ResponseProtein C (Activated)Coagulation ProcessAdult
Grant awards (19)
Analysis and Characterization of Trauma-Induced Coagulopathy$1,251,165
UM1 · FY2017 · HL · contact PI
Analysis and Characterization of Trauma-Induced Coagulopathy$4,800,000
UM1 · FY2016 · HL · contact PI
Analysis and Characterization of Trauma-Induced Coagulopathy$4,728,000
UM1 · FY2015 · HL
Analysis and Characterization of Trauma-Induced Coagulopathy$4,704,000
UM1 · FY2014 · HL
Analysis and Characterization of Trauma-Induced Coagulopathy$4,569,600
UM1 · FY2013 · HL
Validation of extracellular histones as biomarker and therapeutic target in sepsi$500,000
RC1 · FY2010 · GM
Validation of extracellular histones as biomarker and therapeutic target in sepsi$500,000
RC1 · FY2009 · GM
Roles of EPCR and PAR I in Acute Lung Injury$3,044
P50 · FY2007 · HL · contact PI
COBRE: OK MED RES FOUND: ADMINISTRATIVE CORE$181,072
P20 · FY2006 · RR · contact PI
Roles of EPCR and PAR I in Acute Lung Injury$2,000
P50 · FY2006 · HL · contact PI
Post-Translational Modifications in Host Defense$2,000,260
P20 · FY2005 · RR
ENDOTHELIAL CELL PROTEIN C RECEPTOR$248,496
P50 · FY2005 · HL
COBRE: OK MED RES FOUND: ADMINISTRATIVE CORE$186,724
P20 · FY2005 · RR
Roles of EPCR and PAR I in Acute Lung Injury$2,000
P50 · FY2005 · HL
Post-Translational Modifications in Host Defense$2,001,402
P20 · FY2004 · RR
ENDOTHELIAL CELL PROTEIN C RECEPTOR$241,258
P50 · FY2004 · HL
Roles of EPCR and PAR I in Acute Lung Injury$2,000
P50 · FY2004 · HL
Roles of EPCR and PAR I in Acute Lung Injury$2,000
P50 · FY2003 · HL
ENDOTHELIAL CELL PROTEIN C RECEPTOR$0
P50 · FY2002 · HL